Chiba University Hospital
Chiba, Chiba 260-8677
4 studies enrolling now · 7 studies all time
What they study most
Atrial Fibrillation, Bronchiectasis, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Focal Segmental Glomerulosclerosis, Hypertension, Idiopathic Pulmonary Fibrosis, Percutaneous Coronary Intervention, Progressive Pulmonary Fibrosis, Schizophrenia
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast — Recruiting now
- The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
- A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS) — Recruiting now
- A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) — Completed
- Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia — Completed
- Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed